Alto Ingredients earnings release, May 6, 2026

Alto Ingredients, Inc. (ALTO) · Form 8-K, Item 2.02 · Filed · SEC filing

Alto Ingredients, Inc. Reports First Quarter

2026 Results

Q1 2026 Gross Profit of $9.2 Million Increased

$11.0 Million

Q1 2026 Net Income of $4.0 Million, or $0.05 per Share, Improved $16.0 Million

Q1 2026 Adjusted EBITDA of $4.7 Million Improved $9.1 Million Compared to Q1 2025

Pekin, Ill., May 6, 2026 – Alto Ingredients, Inc. (NASDAQ: ALTO), a producer and distributor of renewable fuels, essential ingredients and specialty alcohols, reported its financial results for the quarter ended March 31, 2026.

“In a seasonally weak period for Alto and the industry, we delivered profitability on an adjusted EBITDA and net income basis through the contributions of strong export sales, higher crush margins and incremental earnings from Section 45Z tax credits. Even without the contribution of the tax credits we were profitable,” said President and Chief Executive Officer Bryon McGregor. “Our strategic realignment, combined with our efforts to improve our operational model and the stability of our business have enhanced our earnings power.”

Added Mr. McGregor, “Looking ahead, our priorities are straightforward: improve utilization and reliability; execute our 2026 optimization and capital projects on time and on budget; and leverage the flexibility we have with multiple revenue streams to respond to market shifts and perform profitably through commodity cycles. In addition, we are focused on expanding the value we capture from 45Z tax credits and on optimally monetizing the value of our biogenic CO² production across our facilities to lower our carbon footprint. Through our focus on these priorities, we remain committed to enhancing the value of our assets.”

Financial Results for the Three Months Ended

March 31, 2026 Compared to 2025

Cash and cash equivalents at March 31, 2026 were $20.3 million, compared to $23.4 million at December 31, 2025. The company’s borrowing availability at March 31, 2026 was $94.3 million, including $29.3 million under the company’s operating line of credit and $65 million under its term loan facility.

First Quarter 2026 Results Conference Call

Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Wednesday, May 6, 2026, and will deliver prepared remarks via webcast followed by a question-and-answer session.

To receive a number and unique PIN by email, register here. To dial directly up to 20 minutes prior to the scheduled call time, please dial (833) 630-0017 domestically and (412) 317-1806 internationally.

Alternatively, the webcast for the conference call can be accessed from Alto Ingredients’ website at www.altoingredients.com and will be available for one year.

Use of Non-GAAP Measures

Management believes that certain financial measures not in accordance with generally accepted accounting principles ("GAAP") are useful measures of operations. The company defines

Adjusted EBITDA as unaudited consolidated net income (loss) before interest expense, interest income, provision (benefit) for income taxes, asset impairments, unrealized derivative gains and losses, acquisition-related expense, excess insurance proceeds and depreciation and amortization expense. A table is provided at the end of this release that provides a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss). Management provides this non-GAAP measure so that investors will have the same financial information that management uses, which may assist investors in properly assessing the company's performance on a period-over-period basis. Adjusted

EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool, and you should not consider this measure in isolation or as a substitute for analysis of the company's results as reported under GAAP.

About Alto Ingredients, Inc.

Alto Ingredients, Inc. (NASDAQ: ALTO) is a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients. Leveraging the unique qualities of its facilities, the company serves customers in a wide range of consumer and commercial products in the Health, Home & Beauty; Food & Beverage;

Industry & Agriculture; Essential Ingredients; and Renewable Fuels markets. For more information, please visit www.altoingredients.com.²

Safe Harbor Statement under the Private

Securities Litigation Reform Act of 1995

Financial statements

Income Statement

Three Months Ended March 31, — (unaudited, in thousands, except per share data)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Net sales224,680226,540
Cost of goods sold215,461228,347
Gross profit (loss)9,219-1,807
Selling, general and administrative expenses6,6997,190
Income (loss) from operations2,520-8,997
Interest expense, net-2,198-2,729
Transferable tax credits, net3,900
Other income, net4947
Income (loss) before provision for income taxes4,271-11,679
Net income (loss)4,271-11,679
Preferred stock dividends-312-312
Net income (loss) attributable to common stockholders3,959-11,991
Net income (loss) per share, basic0.05-0.16
Net income (loss) per share, diluted0.05-0.16
Weighted-average shares outstanding, basic74,78973,836
Weighted-average shares outstanding, diluted76,63973,836

Income Statement

Three Months Ended March 31, — Reconciliation of Adjusted EBITDA to Net Income (Loss) (in thousands)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Net income (loss)4,271-11,679
Adjustments:Interest expense2,1982,729
Adjustments:Interest income-77-84
Adjustments:Unrealized derivatives gains-8,073-1,634
Adjustments:Depreciation and amortization expense6,3666,266
Adjustments:Total adjustments4147,277
Adjustments:Adjusted EBITDA4,685-4,402

Income Statement

Three Months Ended March 31, — Segment Financials (in thousands)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Pekin Campus production:Alcohol sales107,952107,234
Pekin Campus production:Essential ingredient sales43,99344,618
Pekin Campus production:Intersegment sales262297
Pekin Campus production:Total Pekin Campus sales152,207152,149
Marketing and distribution:Alcohol sales47,32649,058
Marketing and distribution:Intersegment sales2,4502,506
Marketing and distribution:Total marketing and distribution sales49,77651,564
Western production:Alcohol sales16,68016,194
Western production:Essential ingredient sales7,2807,808
Western production:Intersegment sales399264
Western production:Total Western production sales24,35924,266
Western production:Corporate and other1,4491,628
Western production:Intersegment eliminations-3,111-3,067
Western production:Net sales as reported224,680226,540
Cost of goods sold:Pekin Campus production144,021155,222
Cost of goods sold:Marketing and distribution46,03747,650
Cost of goods sold:Western production25,50225,524
Cost of goods sold:Corporate and other1,0361,681
Cost of goods sold:Intersegment eliminations-1,135-1,730
Cost of goods sold:Cost of goods sold as reported215,461228,347
Gross profit (loss):Pekin Campus production8,186-3,073
Gross profit (loss):Marketing and distribution3,7393,914
Gross profit (loss):Western production-1,143-1,258
Gross profit (loss):Corporate and other413-53
Gross profit (loss):Intersegment eliminations-1,976-1,337
Gross profit (loss):Gross profit (loss) as reported9,219-1,807

Balance Sheet

March 31, 2026 — (unaudited, in thousands, except par value)

March 31, 2026December 31, 2025
Current Assets:Cash and cash equivalents20,30923,415
Current Assets:Restricted cash1,3342,258
Current Assets:Accounts receivable, net59,70055,069
Current Assets:Inventories52,83161,676
Current Assets:Derivative instruments7,831525
Current Assets:Transferable tax credits, net11,5307,500
Current Assets:Other current assets5,0175,474
Current Assets:Total current assets158,552155,917
Current Assets:Property and equipment, net193,199198,501
Other Assets:Right of use operating lease assets, net17,21516,931
Other Assets:Intangible assets, net7,4197,574
Other Assets:Other assets9,9089,863
Other Assets:Total other assets34,54234,368
Other Assets:Total Assets386,293388,786

Balance Sheet

LIABILITIES AND STOCKHOLDERS’ EQUITY — (unaudited, in thousands, except par value)

March 31, 2026December 31, 2025
Current Liabilities:Accounts payable19,30314,509
Current Liabilities:Accrued liabilities12,33216,691
Current Liabilities:Current portion – long-term debt16,600
Current Liabilities:Current portion – operating leases4,9754,958
Current Liabilities:Derivative instruments3011,067
Current Liabilities:Other current liabilities4,7415,246
Current Liabilities:Total current liabilities41,65259,071
Current Liabilities:Long-term debt73,05663,027
Current Liabilities:Operating leases, net of current portion13,24013,012
Current Liabilities:Other liabilities8,4678,435
Current Liabilities:Total Liabilities136,415143,545
Stockholders’ Equity:Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: no shares issued and outstanding as of March 31, 2026 and December 31, 2025 Series B: 927 shares issued and outstanding as of March 31, 2026 and December 31, 202511
Stockholders’ Equity:Common stock, $0.001 par value; 300,000 shares authorized; 77,946 and 77,307 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively7877
Stockholders’ Equity:Additional paid-in capital1,052,4721,051,795
Stockholders’ Equity:Accumulated other comprehensive income5,4615,461
Stockholders’ Equity:Accumulated deficit-808,134-812,093
Stockholders’ Equity:Total Stockholders’ Equity249,878245,241
Stockholders’ Equity:Total Liabilities and Stockholders’ Equity386,293388,786
Full release

Statements and information contained in this communication that refer to or include Alto Ingredients’ estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients’ current perspective of existing trends and information as of the date of the communication. Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,”

“plan,” “could,” “should,” “estimate,” “expect,” “forecast,” “outlook,”

“guidance,” “intend,” “may,” “might,” “will,” “possible,” “potential,”

“predict,” “project,” or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning Alto Ingredients’ expectations around profitability and executing on opportunities to grow earnings, including through improved utilization and reliability, optimization and capital projects, monetizing additional Section

45Z tax credits and monetizing the value of its biogenic CO² to lower its carbon footprint; and Alto Ingredients’ other plans, objectives, expectations and intentions. It is important to note that Alto Ingredients’ plans, objectives, expectations and...ntions are not predictions of actual performance. Actual results may differ materially from Alto Ingredients’ current expectations depending upon a number of factors affecting Alto Ingredients’ business and plans. These factors include, among others adverse economic and market conditions, including for renewable fuels, specialty alcohols and essential ingredients; export conditions and international demand for the company’s products; fluctuations in the price of and demand for oil and gasoline; raw material costs, including production input costs, such as corn and natural gas; adverse impacts of inflation and supply chain constraints, including from tariffs; Alto Ingredients’ ability to timely and within budget execute on its optimization and capital projects; Alto Ingredients’ ability to expand and monetize the value of its CO² production to lower its carbon footprint; regulatory developments and Alto Ingredients’ ability to successfully pursue and secure opportunities, and realize the expected results, under existing and new legislation, including the Section

45Z regulations, and to successfully apply for and receive anticipated credit amounts. These factors also include, among others, the inherent uncertainty associated with financial and other projections; the anticipated size of the markets and continued demand for Alto Ingredients’ products; the impact of competitive products and pricing; the risks and uncertainties normally incident to the alcohol production, marketing and distribution industries; changes in generally accepted accounting principles; successful compliance with governmental regulations applicable to Alto Ingredients’ facilities, products and/or businesses; changes in laws, regulations and governmental policies; the loss of key senior management or staff; and other events, factors and risks previously and from time to time disclosed in Alto Ingredients’ filings with the Securities and Exchange Commission including, specifically, those factors set forth in the “Risk Factors” section contained in Alto Ingredients’ Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 13,

2026.

Company IR and Media Contact:

Michael Kramer, Alto Ingredients, Inc., 916-403-2755

Investorrelations@altoingredients.com

IR Agency Contact:

Jody Burfening, Alliance Advisors Investor Relations,

212-838-3777,

Investorrelations@altoingredients.com³

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Alto Ingredients earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.